Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular Tissue Levels of 1.5% Levofloxacin in Cataract Surgery
NCT00630019Phase 4Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Feb 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin in Bacterial ocular infection, sponsored by Santen Pharmaceutical. Started Feb 2008; status: completed.
02
Drugs
levofloxacin
03
Conditions
Bacterial ocular infection
Beyond the preview
Go deeper on NCT00630019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630019.